[ad_1]
The Mexican Government is studying the case of a doctor with an allergic history who is in intensive care for developing encephalitis, an inflammation in the brain, after receiving the Pfizer and BioNTech vaccine against COVID-19.
“With the scientific evidence available from the clinical trials of the vaccine Pfizer-BioNTech BNT162b2 against the SARS-CoV-2 virus, no person had previously presented encephalitis after the application of the vaccine,” reported this Saturday (01.02.2021) the Ministry of Health (SSa) in a statement.
The government agency specified that the woman is a 32-year-old doctor from the Mexican Institute of Social Security (IMSS) in the northern state of Nuevo León, where she received the drug this week.
History of allergic reactions to medications
The doctor, said the SSa, has a history of allergic reactions to drugs such as trimethoprim with sulfamethoxazole, an antibiotic that fights urinary infections.
Its initial diagnosis is encephalomyelitis, which is described as a brief but intense attack of inflammation in the brain, usually from a viral infection.
The woman developed a skin rash, seizures, decreased muscle strength, and respiratory distress within half an hour after the dose was applied.
“The reaction was detected within the specific observation area of the vaccination cell in which the doctor received her vaccine,” indicated the SSa.
More than 126,500 people have died from COVID-19 in Mexico. The country began distributing the first round of COVID-19 vaccines to healthcare workers on December 24.
The country has pre-purchase contracts for 34.4 million doses from Pfizer, 77.4 million from the British AstraZeneca, 35 million from the Chinese CanSino and 34.4 million from the Covax platform of the World Health Organization (WHO) .
[ad_2]
